CMPR CIMPRESS plc
Commercial Printing · Nasdaq · SEC CIK 1262976 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY10.0%
TTM net income YoY143.5%
TTM EPS YoY144.9%
Revenue 3-yr CAGR6.7%
Net income 3-yr CAGR—
Margins
Gross margin45.6%
Operating margin6.0%
Net margin2.2%
FCF margin5.0%
EBITDA margin10.2%
Returns
ROE—
ROA4.1%
ROIC (approx.)16.6%
Asset turnover1.81x
Leverage & solvency
Liabilities / assets117.9%
Debt / equity—
Current ratio0.63x
Interest coverage—
Cash quality & payout
Operating cash flow / net income3.36x
Accruals ratio-9.6%
Payout ratio—
Capex / revenue2.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 |
|---|---|---|
| Income statement | ||
| Revenue | $3.74B | $3.40B |
| Cost of revenue | $2.01B | $1.79B |
| Gross profit | $1.73B | $1.62B |
| R&D expense | $68.60M | $65.00M |
| SG&A expense | $235.31M | $218.53M |
| Operating income | $251.03M | $226.27M |
| Pretax income | $152.89M | $96.96M |
| Income tax | $55.78M | $84.11M |
| Net income | $95.87M | $14.95M |
| EBITDA | $402.86M | $367.40M |
| EPS (basic) | 3.93 | 0.60 |
| EPS (diluted) | 3.79 | 0.58 |
| Weighted avg. shares (diluted) | 25.33M | 25.64M |
| Banking | ||
| Net interest income | -$105.75M | -$115.23M |
| Balance sheet | ||
| Cash & equivalents | $248.85M | $233.98M |
| Short-term investments | — | $0 |
| Receivables | $73.62M | $68.29M |
| Inventory | $136.98M | $112.87M |
| Current assets | $564.45M | $502.61M |
| PP&E, net | $367.16M | $302.49M |
| Goodwill | $850.78M | $826.16M |
| Intangibles | $70.58M | $58.35M |
| Total assets | $2.20B | $1.97B |
| Current liabilities | $775.59M | $758.66M |
| Short-term debt | $14.62M | $9.09M |
| Long-term debt | $1.60B | $1.58B |
| Total debt | $1.61B | $1.59B |
| Total liabilities | $2.60B | $2.53B |
| Shareholders' equity | -$493.99M | -$583.49M |
| Net debt | $1.36B | $1.35B |
| Shares outstanding | 24.35M | 24.48M |
| Cash flow statement | ||
| Operating cash flow | $283.71M | $298.07M |
| Capital expenditure | $100.24M | $89.02M |
| Free cash flow | $183.46M | $209.05M |
| Investing cash flow | -$195.56M | -$140.76M |
| Financing cash flow | -$68.02M | -$135.92M |
| Depreciation & amortization | $151.84M | $141.13M |
| Stock-based compensation | $61.38M | $58.88M |
| Share buybacks | $50.08M | $77.78M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.